LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Startup Investment Opportunities
Real Estate & Property Management Companies for Sale
Convenience Stores & Lotto Businesses For Sale
Construction & Landscaping Businesses for Sale
Healthcare & Medical Businesses for Sale
Transport & Shipping Businesses for Sale
Clothing & Shoe Stores for Sale
Smoke & Vape Shops for Sale
Retirement Homes for Sale
Furniture & Home Decor Businesses for Sale
Smoke & Vape Shop Franchises for Sale
Senior Care Franchise for Sale
Consultancy & Training Franchise Opportunities
Environmental Franchise Opportunities
Laundromat & Dry Cleaning Franchise Opportunities
Bars & Pubs Franchises for Sale
Finance & Accounting Franchise Opportunities
Post Office Franchises for Sale
Healthcare & Medical Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Office Spaces for Sale or Rent
Apartment Buildings for Sale
Industrial Buildings for Sale or Lease
Retail Buildings for Sale or Lease
Plazas for Sale
Commercial Spaces for Sale or Lease
Commercial Buildings for Sale or Lease
Houses & Condos for Sale or Lease
Industrial Units for Sale or Rent
Medical Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: